Characterization of Escherichia coli urinary tract infection isolates in remote northern Saskatchewan communities: The Northern Antibiotic Resistance Partnership

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 3, 2012, Pages 242-247

  Golding, George R ^a   Persaud, Nadia ^b   Levett, Paul N ^c   McDonald, Ryan R ^c   Irvine, James ^d   Nsungu, Mandiangu ^e   Woods, Shirley ^e   Khan, Mohammad ^f   Mataseje, Laura F ^a   Mulvey, Michael R ^a,b   Horsman, Greg ^c   Nagle, Evelyn ^c   Schachtel, Christine ^c   Schwickrath, Christina ^c   Obarianyk, Arlene ^c   Hansen, Toni ^c   Stockdale, Donna ^d   Quinn, Brian ^d   Mishak Beckman, Brenda ^g   Johnson, Jill ^g   Malmgren, Pat ^h   Cholin, Brenda ⁱ   Whitecap, Zachary ^j   Brooke, Barb ^j   McKay, Matilda ^j   Bear, Ruth ^k   Quinney, Georgina ^k   Bear, Annel ^k   Paton, Shirley ^l   Ofner Agostini, Marianna ^l   Szclarzuk, Brian ^l   Silcox, Steve ^l   Embil, John ^b   Bergstrom, Kirsten ^b   Horbal, Amanda ^b   Siemens, Christine ^b   more..

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Saskatchewan Disease Control Laboratory   (Canada)

^d Population Health Unit   (Canada)

^e Northern Intertribal Health Authority   (Canada)

^f Kelsey Trail Health Region   (Canada)

^g SASKATOON HEALTH REGION   (Canada)

^h Keewatin Yatthé Regional Health Authority   (Canada)

ⁱ Saskatchewan   (Canada)

^j Red Earth First Nation   (Canada)

^k Shoal Lake Cree Nation   (Canada)

^l PUBLIC HEALTH AGENCY OF CANADA   (Canada)

more..

Author keywords

Community; Escherichia coli; NARP; ST131; Urinary tract infections; Uropathogenic

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CARBACEPHEM DERIVATIVE; CEFALEXIN; CEFEPIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MONOBACTAM DERIVATIVE; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CANADA; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; INFANT; INTEGRON; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PLASMID; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REPLICON; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; URINARY TRACT INFECTION;

EID: 84867630094     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.07.003     Document Type: Article

References (26)

1. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: 17th informational supplement CLSI document (M100-S17) 2007, CLSI, Wayne, PA.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003, 49:53-70.
3. Foxman B., Barlow R., D'Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000, 10:509-515.
4. Golding G.R., Levett P.N., McDonald R.R., Irvine J., Nsungu M., Woods S., et al. A comparison of risk factors associated with community-associated methicillin-resistant and -susceptible Staphylococcus aureus infections in remote communities. Epidemiol Infect 2010, 138:730-737. Northern Antibiotic Resistance Partnership (NARP).
5. Golding G.R., Levett P.N., McDonald R.R., Irvine J., Quinn B., Nsungu M., et al. High rates of Staphylococcus aureus USA400 infection, northern Canada. Emerg Infect Dis 2011, 17:722-725. Northern Antibiotic Resistance Partnership.
6. Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52:e103-e120. Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases.
7. Johnson J.R., Manges A.R., O'Bryan T.T., Riley L.R. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 2002, 359:2249-2251.
8. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009, 53:2733-2739.
9. Johnson J.R., Menard M.E., Lauderdale T.L., Kosmidis C., Gordon D., Collignon P., et al. Global distribution and epidemiologic associations of Escherichia coli clonal group A, 1998-2007. Emerg Infect Dis 2011, 17:2001-2009. Trans-Global Initiative for Antimicrobial Resistance Analysis Investigators.
10. Johnson J.R., Nicolas-Chanoine M.H., DebRoy C., Castanheira M., Robicsek A., Hansen G., et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012, 18:598-607. MASTER Investigators.
11. Johnson T.J., Wannemuehler Y.M., Johnson S.J., Logue C.M., White D.G., Doetkott C., et al. Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl Environ Microbiol 2007, 73:1976-1983.
12. Koeleman J.G., Stoof J., Van Der Bijl M.W., Vandenbroucke-Grauls C.M., Savelkoul P.H. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001, 39:8-13.
13. Lagace-Wiens P.R., Simner P.J., Forward K.R., Tailor F., Adam H.J., Decorby M., et al. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada-results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011, 69:314-319. Canadian Antimicrobial Resistance Alliance (CARA).
14. Levesque C., Piche L., Larose C., Roy P.H. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995, 39:185-191.
15. Manges A.R., Johnson J.R., Foxman B., O'Bryan T.T., Fullerton K.E., Riley L.W. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001, 345:1007-1013.
16. Manges A.R., Tabor H., Tellis P., Vincent C., Tellier P.-P. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 2008, 14:1575-1583.
17. Mammeri H., Van De Loo M., Poirel L., Martinez-Martinez L., Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005, 49:71-76.
18. Mataseje L.F., Boyd D.A., Willey B.M., Prayitno N., Kreiswirth N., Gelosia A., et al. Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring blaKPC from New York City and Toronto. J Antimicrob Chemother 2011, 66:1273-1277.
19. Mora A., López C., Dabhi G., Blanco M., Blanco J.E., Alonso M.P., et al. Extraintestinal pathogenic Escherichia coli O1:K1:H7/NM from human and avian origin: detection of clonal groups of B2 ST95 and D ST59 with different host distribution. BMC Microbiol 2009, 9:132.
20. Mulvey M.R., Bryce E., Boyd D., Ofner-Agostini M., Christianson S., Simor A.E., et al. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 2004, 48:1204-1214. Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada.
21. Peirano G., Richardson D., Nigrin J., McGeer A., Loo V., Toye B., et al. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 2010, 54:1327-1330.
22. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
23. Simner P.J., Zhanel G.G., Pitout J., Tailor F., McCracken M., Mulvey M.R., et al. Prevalence and characterization of extended-spectrum beta-lactamase- and AmpC beta-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011, 69:326-334. Canadian Antimicrobial Resistance Alliance (CARA).
24. Simner P.J., Hoban D.J., Lagace-Wiens P.R., Zhanel G.G., Karlowsky J.A. Fluoroquinolone resistance in Escherichia coli isolated from patients attending Canadian hospitals is associated with the ST131 clone. Diagn Microbiol Infect Dis 2011, 71:323-324.
25. Tivendale K.A., Logue C.M., Kariyawasam S., Jordan D., Hussein A., Li G., et al. Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infect Immun 2010, 78:3412-3419.
26. Vincent C., Boerlin P., Daignault D., Dozois C.M., Dutil L., Galanakis C., et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis 2010, 16:88-95.